Standout Papers

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast ca... 2011 2026 2016 2021 788
  1. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (2011)
    Javier Cortés, Joyce O’Shaughnessy et al. The Lancet

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
6 intermediate papers

Works of Seth Seegobin being referenced

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011 Standout

Author Peers

Author Last Decade Papers Cites
Seth Seegobin 783 289 105 249 20 1.3k
Gerard Cowley 424 137 65 122 27 1.0k
Christian Kersting 436 290 126 288 42 1.5k
Eugene Einhorn 534 287 184 180 22 1.3k
Hector Arango 324 101 17 218 15 1.2k
Fiona Knox 585 262 14 553 26 1.2k
G A Lammie 237 322 56 132 23 1.2k
Sarah Hatsell 462 144 314 147 32 1.5k
R. Faggiuolo 1346 364 12 137 23 1.7k
Timothy Semple 139 165 135 119 28 1.2k
Veronica Vergani 355 186 25 268 21 1.1k

All Works

Loading papers...

Rankless by CCL
2026